Can I use a vendor agent and still keep my data private?

Sometimes: check the BAA, data-retention terms, and explicitly whether your data is used to train the vendor's models. If any of those are unacceptable for your PHI, that pushes you toward building inside your own boundary.

What is the fastest way to decide whether to build or buy an AI agent?

Use a three-question build vs buy decision framework for healthcare AI agents: Does this agent differentiate us? Does it need deep access to our PHI and workflows? Do we need to own the compliance boundary? If the answers are mostly yes, build. If they are mostly no, buy a proven point solution.

Is building or buying AI agents cheaper to run long term?

Buying is cheaper to start, because per-seat or per-call fees replace build cost. A custom agent costs more up front, and then you pay for hosting, model tokens and the people who run evaluations. At high volume, custom can cost less per task, but only if you have a team to keep it accurate and safe.

How long does it take to build a custom AI agent?

It depends on the workflow the agent automates, how many systems it reads from or writes to, how much evaluation data you have, and how much human review the output needs. A first release scoped to one workflow, with a person approving each action, reaches users soonest. If the task is generic and speed matters most, a vendor agent is usually faster to put in place.

Is it hard to switch from a vendor AI agent to a custom one later?

Less hard if you plan for it. Keep your prompts, test cases and evaluation results in your own repository, agree with the vendor how logs and conversation data come back to you, and put the agent behind your own interface so the workflow does not depend on one vendor's API.

Do regulators or auditors prefer built or bought AI agents?

Neither. If the agent handles PHI, every vendor or model provider in the data path needs a BAA, whether you build or buy. Auditors look for the same evidence either way: who can access data, what the agent did, which model version produced each output, and how you test it. The NIST AI Risk Management Framework is a voluntary structure many teams use to organize that work.

When should an AI chatbot hand off to a human agent?

Hand off when a request needs clinical judgment, when a patient is upset or confused, when there is a billing dispute, or when the bot cannot confirm an answer from its sources. A good handoff passes the conversation and context to staff, so the patient does not repeat themselves. Whether you build or buy, test the handoff rules as carefully as the answers.

Which foundation model should power a healthcare AI agent?

It matters less than teams expect: the leading models (Claude, GPT, Gemini) are all capable enough that the model isn't your moat. What matters more is choosing a provider that will sign a BAA for PHI, then investing in retrieval over your own data, workflow integration, and evaluation. Keep the model swappable so you can move as capability and pricing shift.

How do I stop a healthcare AI agent from hallucinating?

You contain it rather than eliminate it entirely: ground answers in your own data with retrieval (RAG), constrain the agent with tools and guardrails, keep a human in the loop wherever the output is clinical, and run a real evaluation harness against known cases before and after every change. That discipline, not the model choice, is what makes an agent safe enough for healthcare.

Do healthcare AI agents need a BAA?

If the agent processes PHI, yes: you need a signed BAA with any model provider or vendor in the data path, and you should confirm your data isn't used to train their models. If a provider won't sign one, or the terms don't fit your PHI, that's a strong push toward running inference inside your own compliance boundary.

Who controls model version changes in a vendor healthcare AI product?

The vendor does, unless the contract says otherwise. Ask for advance notice of model changes, release notes that say what changed, a test environment where you can rerun your own cases first, and the model version recorded against each output. If a vendor cannot offer those, plan for behavior that can shift between releases without any change on your side.

A workbench with parts and a robot arm beside a sealed product box

Build vs Buy

Build vs Buy: AI Agents in Healthcare

Buy a vendor AI agent for a well-defined, commodity task such as ambient scribing, eligibility checks or appointment voice bots. Build custom when the agent runs your differentiated workflows, needs deep access to clinical data or must stay inside a compliance boundary you control.

15-Minute Scoping Call All Comparisons

What is the difference between building and buying AI agents?

Quick answer

The build vs buy AI agents decision turns on differentiation, data access and who owns the compliance boundary. Buy a proven vendor agent for a well-defined task such as scheduling or eligibility checks. Build when the agent runs a workflow that sets you apart, needs governed access to your PHI, or must coordinate with other agents and tools.

Criterion	Build	Buy
Time to value	Longer (build + eval)	Fast (configure)
Differentiation	High: it's yours	Low: same product others buy
PHI / data control	Full, in your boundary	Shared with vendor
Integration depth	As deep as you build	Vendor's connectors
Compliance ownership	You own it	Vendor BAA + your oversight
Security testing	You test for prompt injection and excessive agency	Vendor tests; you review the results
Handoff to staff	You set when the agent hands off to a person	Vendor's handoff rules
Cost model	Build + infra + model tokens	Per-seat / per-call fees
Maintenance	On you (prompts, evals, drift)	On the vendor

What goes into a custom or a vendor AI agent?

What is Build

Building means composing your own agents on foundation models (Claude, GPT, Gemini) with orchestration, retrieval over your clinical data, tool integrations and guardrails, inside your own compliance boundary. You own the prompts, data flows, evaluation suite and tuning.

What is Buy

Buying means licensing a purpose-built healthcare AI product (an ambient scribe, a prior-auth automation, a patient-communication bot) that's already trained, integrated with common EHRs, and shipped with its own compliance posture (BAA, certifications). You get speed and a maintained product; you accept its boundaries.

Build vs buy AI agents pros and cons

The model isn't the moat

Everyone builds on the same foundation models, so a better LLM isn't a lasting edge. Differentiation lives in your data, your workflow integration and your evaluation and guardrail discipline. If those set the agent apart, build. If the task is generic, buy.

PHI, compliance, and the trust boundary

Healthcare AI agents touch PHI, so where inference runs and how data flows matter. Building keeps everything inside your BAA-covered, audited boundary with data-residency control. Buying means trusting a vendor's compliance posture: check the BAA, retention terms and whether your data trains their models.

Total cost and scale dynamics

Vendor per-seat or per-call pricing is cheap to start and scales with usage. A custom agent carries build cost plus infrastructure and token spend you can optimize. At higher volume, custom economics can win, but only with a team to run evals and manage drift.

Orchestration vs single function

Buying works best for a single, bounded function. If your ambition is a multi-agent system (several agents coordinating across intake, documentation, coding, and follow-up with shared context and tools) that orchestration is inherently custom, even if individual capabilities lean on vendor components.

When should you build or buy an AI agent?

When to use Build (Custom Agents)

The agent automates a workflow that differentiates you, not a commodity task.
It needs deep, governed access to your PHI, EHR, and proprietary data (RAG on clinical records).
You require full control of the compliance boundary, audit trail, and data residency.
You want to avoid per-seat/per-call vendor fees compounding at scale.
You're orchestrating multiple agents and tools into a system, not buying one function.

When to use Buy (Vendor Point Solution)

The task is well-defined and commoditized (scribing, eligibility, scheduling voice AI).
A mature vendor already solves it well with EHR integrations you need.
You want a signed BAA and the vendor's compliance/security work done for you.
You lack ML/LLM engineering capacity and speed matters more than customization.
You're validating whether AI moves the metric before investing in custom.

Should a healthcare GenAI build use a hosted model API or a self-hosted model?

Use a hosted model API when the provider signs a BAA covering the service and its retention and training terms fit your PHI. Self-host an open-weight model when policy, data residency or volume rules out a third party and you can staff the serving work.

Both options sit on the build side of a GenAI healthcare build vs buy decision, so you own the agent. Watch for logging tools that store prompts outside any BAA, and keep the model behind one interface so switching is a re-evaluation, not a rewrite.

Which sources does this comparison rely on?

AI Agents for Healthcare Multi-Agent Systems for Healthcare Generative AI for Healthcare Healthcare RAG / Chat-with-Records How to choose an AI agent framework EMR vs EHR FHIR R4 vs R5 vs R6 FHIR vs HL7 v2

Frequently Asked Questions

Risk comes from weak evaluation and guardrails, not from building per se. A custom agent with a rigorous eval harness, human-in-the-loop where clinically appropriate, and a controlled PHI boundary can be safer than a black-box vendor tool. The discipline matters more than the buy/build choice.

Not sure which fits your build?

Tell us about your product, integration targets, and timeline. We'll map the trade-offs to your context and recommend the path that gets you to a compliant launch fastest.

15-Minute Scoping Call Explore Solutions